Healthy Heart Webinars
The Role of Pharmacists in Prevention of Cardiovascular Disease
16th August 2021 16:00 – 17:15 GMT
Watch a recording of the session:
Please email us if you would like to find out about ways to support our healthy heart charity.
In this webinar on ‘the role of pharmacists in CVD prevention’ from an international perspective, we showcase the various pharmacy professional roles and opportunities to tackle the CVD prevention agenda; drawing synergies and learnings from Canada, England and Germany.
These monthly webinars from healthy heart charity the Cardiovascular Research Trust provide updates for clinicians, patients and carers and the public on prevention, diagnosis and treatment of common and serious clinical disorders related to keeping the heart healthy and reducing the risk of other cardiovascular diseases.
The topics are of interest to a wide range of professionals interested in health, including clinical trainees, senior clinicians, policy makers, academics and other health professionals.
Programme
16:00 – 16:05
Introduction
Prof Donald Singer
Chair, Cardiovascular Research Trust
Anisha Soni
Trustee, Cardiovascular Research Trust
16:05 – 16:20
The role of pharmacists in CVD Prevention: A Canadian Perspective
Prof Ross Tsuyuki
Professor and Chair, Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta
Professor of Medicine (Cardiology) and Director, EPICORE Centre
16:20 – 16:35
The role of pharmacists in CVD Prevention: A German Perspective
Prof Martin Schulz
Adjunct Professor, Institute of Pharmacy, Freie Universitaet Berlin
16:35 – 16:50
The role of pharmacists in CVD Prevention: A UK Perspective
Helen Williams
Consultant Pharmacist for Cardiovascular Disease, South East London Clinical Commissioning Group
National Specialty Adviser for Cardiovascular Disease Prevention, NHS England and NHS Improvement
Clinical Adviser for Cardiovascular Disease, UCL Partners
16:50 – 17:05
Q & A – from the audience
Moderator: Anisha Soni
Trustee, Cardiovascular Research Trust
17:05 – 17:15
Final remarks from the speakers
17:15
Webinar close
More on the speaker sessions:
“I will focus on the role that UK pharmacists can play in the detection and management of the three high risk cardiac conditions, AF, blood pressure and cholesterol (the ABC’s) using examples from community pharmacy, primary care and hospital settings.” ~ Helen Williams, NHS England and NHS Improvement, England.
“I will refer to the available evidence on pharmacists’ intervention in CVD risk reduction and, specifically, address the challenge of medication adherence. Eventually, I will present worksheets for hypertension detection and control developed recently.” ~ Prof. Martin Schulz, Free University, Germany.
“I will speak on the Canadian perspective on CVD prevention by pharmacists. Specifically, I’ll review our trials of pharmacists’ independent prescribing and care in hypertension and CVD risk reduction and mention some of our next steps in implementation: need for case-finding strategies and training programs.” ~ Prof. Ross Tsuyuki, University of Alberta, Canada.
Panel biographies
Prof Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC, FCAHS, ISHF
Professor and Chair, Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta
Professor of Medicine (Cardiology) and Director, EPICORE Centre
Dr. Ross Tsuyuki was born and raised in Vancouver, BC, Canada. His training includes:
- BSc(Pharm) from the University of British Columbia
- Residency at St. Paul’s Hospital, Vancouver.
- Postgraduate Doctor of Pharmacy (PharmD) from the State University of New York at Buffalo
- Postdoctoral fellowship in cardiovascular clinical trials in the Division of Cardiology at McMaster University, Hamilton, Ontario (Supervisor: Dr. Salim Yusuf)
- MSc in Health Research Methods from McMaster University
Dr. Tsuyuki is currently Professor and Chair, Department of Pharmacology in the Faculty of Medicine and Dentistry at the University of Alberta. He is also a Professor of Medicine (Cardiology) and Director of the EPICORE Centre in the Department of Medicine. Dr. Tsuyuki has received several awards for teaching and mentorship, as well as appointment as a Fellow of the Canadian Society of Hospital Pharmacists (FCSHP), the American College of Cardiology (FACC), the Canadian Academy of Health Sciences (FCAHS), and the International Society of Hypertension (ISHF). In 2005, he was recognized as the Canadian Pharmacist of the Year by the Canadian Pharmacists Association. Dr. Tsuyuki is currently the President of Hypertension Canada. His research interests include interventional health services research and in the provision of support for other researchers and training the next generation of health researchers, which is provided through his research group, EPICORE Centre (www.epicore.ualberta.ca).
Prof Martin Schulz, FFIP, FESCP
Adjunct Professor, Institute of Pharmacy, Freie Universitaet Berlin
Martin is an Adjunct Professor at the Institute of Pharmacy, Freie Universität Berlin and Chairman of the Drug Commission of German Pharmacists (AMK). In his main job, he is the Managing Director of the Department of Medicine of ABDA – Federal Union of German Associations of Pharmacists, Berlin (www.abda.de). In addition, he is Director Pharmacy of the German Institute for Drug Use Evaluation (www.dapi.de). He graduated as a pharmacist from the University of Hamburg, Germany, in 1983. From 1983-1984, he was a hospital pharmacist, and studied Medicine at the University of Hamburg from 1984-1986. In 1988, he obtained his PhD in Pharmacology from the University of Hamburg. In 1989, he was named “Expert in Pharmacology” by the German Society for Experimental and Clinical Pharmacology and Toxicology. He specialized as a “Drug Information Pharmacist” in 1993. He was appointed as an Adjunct Professor at the Department of Pharmacology, Goethe-University Frankfurt at Main in 2005. Medication adherence; Benefit assessment (AMNOG); Medicines management; Medication safety; Pharmacoepidemiology; Pharmacy Practice Research/Translational Pharmacy; Drug information and drug supply and -usage are some of the areas he has expertise.
Helen Williams FFRPS, FRPharmS
Consultant Pharmacist for Cardiovascular Disease, South East London Clinical Commissioning Group
National Specialty Adviser for Cardiovascular Disease Prevention, NHS England and NHS Improvement
Clinical Adviser for Cardiovascular Disease, UCLPartners
Helen is the National Speciality Adviser for CVD Prevention at NHSE&I and is working on delivery of the CVD ambitions for AF, Blood Pressure and Cholesterol in line with the Long-Term Plan. Helen has worked as a CVD specialist for more than 25 years in hospital, community, and primary care settings. She has led on the development and implementation of consensus evidence-based CVD guidance for use across South London covering a population of 3.6million and supported local practitioners through education and training, guideline implementation, clinical audit, service development and provision of virtual or face to face clinics. She was clinical adviser to the national AF AHSN programme and developed the pharmacist-led virtual clinic model to optimise uptake of anticoagulation in AF, which is now being spread nationally through the NHSE AF demonstrator programme. She is currently working at UCLP on the development and implementation of long-term conditions packages designed to support primary care in the post COVID-19 environment. Helen is the National Speciality Adviser for CVD Prevention at NHSE&I and is working on delivery of the CVD ambitions for AF, Blood Pressure and Cholesterol in line with the Long-Term Plan.
Anisha Soni is a trustee of the Cardiovascular Research Trust. She is a pharmacist and current clinical
fellow at NHS England & NHS Improvement where she works on system-wide pharmacy projects relating to population health and work-force development. Prior to this, Anisha worked on the NHS front-line for 10 years and taught at the University of Reading as a senior teaching fellow. Anisha specialised as a Cardiac & Critical Care Pharmacist at Oxford University Hospitals NHS Foundation Trust, where she worked as a certified prescriber supporting and optimising medical management of patients who had or were at risk of having a heart attack. Anisha is as advocate for healthcare leadership and education, and is passionate about public health and preventative medicine, having recently gained a Masters in Public Health from London School of Hygiene & Tropical Medicine. To keep active and feed her creativity she enjoys running and art.
Donald Singer is chair of the Cardiovascular Research Trust. He is President of the Fellowship of Postgraduate Medicine and former Secretary of the European Association for Clinical Pharmacology and Therapeutics. He is a member of the Health Professionals Working Party of the European Medicines Agency. He has worked for the University of Yale and the St George’s University Hospital London and has worked on medicine and patients safety as a pharmacologist within the 7 year Human Resources for Health programme in Rwanda, which aims to create a high quality national health system for the country. He was also foundation holder of the Chair of Clinical Pharmacology and Therapeutics at the Graduate Medical School at Warwick University where he founded the Clinical Sciences Division in 2003. He is an active clinician with clinical interests in prevention and treatment of cardiovascular disease and safe use of medicines. His main research interests are in causes of vascular disease, better management of blood pressure and improved patient safety through new systems aimed at improving safety in prescribing. In 2009, with international poet Michael Hulse, he launched the annual International Hippocrates Prize for Poetry and Medicine, which has attracted interest from over 70 countries.
The Healthy Heart Charity 